263 related articles for article (PubMed ID: 17134734)
21. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.
Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F
Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
Kaleem Z; Hassan A; Pathan MH; White G
Arch Pathol Lab Med; 2004 Feb; 128(2):181-6. PubMed ID: 14736286
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
[TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
[TBL] [Abstract][Full Text] [Related]
26. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature.
Gheorghe G; Albano EA; Porter CC; McGavran L; Wei Q; Meltesen L; Danielson SM; Liang X
J Pediatr Hematol Oncol; 2007 Feb; 29(2):112-6. PubMed ID: 17279008
[TBL] [Abstract][Full Text] [Related]
27. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic abnormalities in reactive lymphoid hyperplasia: byproducts of the germinal centre reaction or indicators of lymphoma?
Sevilla DW; Murty VV; Sun XL; Nandula SV; Mansukhani MM; Alobeid B; Bhagat G
Hematol Oncol; 2011 Jun; 29(2):81-90. PubMed ID: 20687199
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B
Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
Ranganathan S; Webber S; Ahuja S; Jaffe R
Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
[TBL] [Abstract][Full Text] [Related]
31. Histological varieties of Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in middle-aged and elderly patients: a study of six cases.
Kojima M; Sugiura I; Itoh H; Shimizu K; Murayama K; Motoori T; Shimano S; Masawa N; Nakamura S
Pathol Res Pract; 2006; 202(8):609-15. PubMed ID: 16824704
[TBL] [Abstract][Full Text] [Related]
32. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
[TBL] [Abstract][Full Text] [Related]
33. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.
Glotz D; Chapman JR; Dharnidharka VR; Hanto DW; Castro MC; Hirsch HH; Leblond V; Mehta AK; Moulin B; Pagliuca A; Pascual J; Rickinson AB; Russo FP; Trappe RU; Webster AC; Zuckermann AO; Gross TG
Transplantation; 2012 Oct; 94(8):784-93. PubMed ID: 22992767
[TBL] [Abstract][Full Text] [Related]
34. Trisomy 3, a sole recurrent cytogenetic abnormality in pediatric polymorphic post-transplant lymphoproliferative disorder (PTLD).
Shestakova A; Grove N; Said J; Song S; Quintero-Rivera F
Cancer Genet; 2020 Oct; 248-249():39-48. PubMed ID: 33065430
[TBL] [Abstract][Full Text] [Related]
35. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
Babel N; Vergopoulos A; Trappe RU; Oertel S; Hammer MH; Karaivanov S; Schneider N; Riess H; Papp-Vary M; Neuhaus R; Gondek LP; Volk HD; Reinke P
Transplantation; 2007 Aug; 84(3):387-91. PubMed ID: 17700165
[TBL] [Abstract][Full Text] [Related]
36. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders.
Craig FE; Johnson LR; Harvey SA; Nalesnik MA; Luo JH; Bhattacharya SD; Swerdlow SH
Diagn Mol Pathol; 2007 Sep; 16(3):158-68. PubMed ID: 17721324
[TBL] [Abstract][Full Text] [Related]
38. Primary central nervous system posttransplant lymphoproliferative disorders.
Castellano-Sanchez AA; Li S; Qian J; Lagoo A; Weir E; Brat DJ
Am J Clin Pathol; 2004 Feb; 121(2):246-53. PubMed ID: 14983939
[TBL] [Abstract][Full Text] [Related]
39. CD30 expression and survival in posttransplant lymphoproliferative disorders.
Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
[No Abstract] [Full Text] [Related]
40. Posttransplant lymphoproliferative disorder in pediatric patients.
Hussein K; Tiede C; Maecker-Kolhoff B; Kreipe H
Pathobiology; 2013; 80(6):289-96. PubMed ID: 24013821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
